[Federal Register Volume 86, Number 52 (Friday, March 19, 2021)]
[Notices]
[Page 14894]
[FR Doc No: 2021-05722]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER21-1372-000]

Diamond Retail Energy, LLC; Supplemental Notice That Initial
Market-Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced Diamond
Retail Energy, LLC's application for market-based rate authority, with
an accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE, Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is April 5, 2021.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically may mail similar pleadings to
the Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426. Hand delivered submissions in docketed
proceedings should be delivered to Health and Human Services, 12225
Wilkins Avenue, Rockville, Maryland 20852.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://www.ferc.gov) using
the ``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at<EMAIL_ADDRESS>or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.

    Dated: March 15, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-05722 Filed 3-18-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 157 (Wednesday, August 14, 2019)]
[Notices]
[Pages 40405-40407]
[FR Doc No: 2019-17404]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2019-0091; FRL-9996-70]

Product Cancellation Order for Certain Pesticide Registrations

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's order for the cancellations,
voluntarily requested by the registrants and accepted by the Agency, of
the products listed in Table 1 of Unit II, pursuant to the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA). This cancellation
order follows a May 29, 2019 Federal Register Notice of Receipt of
Requests from the registrants listed in Table 2 of Unit II to
voluntarily cancel these product registrations. In the May 29, 2019
notice, EPA indicated that it would issue an order implementing the
cancellations, unless the Agency received substantive comments within
the 30-day comment period that would merit its further review of these
requests, or unless the registrants withdrew their requests. The Agency
received comments on the notice but none merited its further review of
the requests. Further, the registrants did not withdraw their requests.
Accordingly, EPA hereby issues in this notice a cancellation order
granting the requested cancellations. Any distribution, sale, or use of
the products subject to this cancellation order is permitted only in
accordance with the terms of this order, including any existing stocks
provisions.

DATES: The cancellations are applicable August 14, 2019.

FOR FURTHER INFORMATION CONTACT: Christopher Green, Information
Technology and Resources Management Division (7502P), Office of
Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2019-0091, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm.,
3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, and the telephone number for the OPP
Docket is<PHONE_NUMBER>. Please review the visitor instructions and
additional information about the docket available at http://www.epa.gov/dockets.

II. What action is the Agency taking?

    This notice announces the cancellation, as requested by
registrants, of products registered under FIFRA section 3 (7 U.S.C.
136a). These registrations are listed in sequence by registration
number in Table 1 of this unit.

                                         Table 1--Product Cancellations
----------------------------------------------------------------------------------------------------------------
        Registration No.           Company No.             Product name                 Active ingredients
----------------------------------------------------------------------------------------------------------------
100-1222.......................             100  Quadris S......................  Azoxystrobin.
279-3555.......................             279  Nuance Herbicide...............  Tribenuron-methyl.
279-3559.......................             279  Harass Herbicide...............  Thifensulfuron.
279-3561.......................             279  Chisum Herbicide...............  Chlorsulfuron & Metsulfuron.
279-3562.......................             279  Report Herbicide...............  Chlorsulfuron.
279-3573.......................             279  Chi-Chlorsul NC-75 Herbicide...  Chlorsulfuron.
279-9633.......................             279  Ciramet Herbicide..............  Metsulfuron.
538-189........................             538  Turf Builder Plus Halts........  Pendimethalin.
538-214........................             538  Proturf Fertilizer Plus          Pendimethalin.
                                                  Preemergent Weed Control.
1015-82........................            1015  Sanafoam Diquat................  Diquat dibromide.
1043-26........................            1043  1-Stroke Environ...............  2-Benzyl-4-chlorophenol; 4-
                                                                                tert-Amylphenol & o-
                                                                                Phenylphenol (NO INERT USE).
1043-87........................            1043  Vesphene II SE.................  4-tert-Amylphenol & o-
                                                                                Phenylphenol (NO INERT USE).
1043-91........................            1043  LPH Master Product.............  4-tert-Amylphenol & o-
                                                                                Phenylphenol (NO INERT USE).
1043-92........................            1043  LPH SE.........................  4-tert-Amylphenol & o-
                                                                                Phenylphenol (NO INERT USE).
1043-114.......................            1043  Vesta-Syde Interim Instrument    4-tert-Amylphenol & o-
                                                  Decontamination Solution.        Phenylphenol (NO INERT USE).
2749-582.......................            2749  Novaluron EC Insecticide.......  Novaluron.
2749-583.......................            2749  Novaluron Technical MUP........  Novaluron.
19713-621......................           19713  Drexel Aquapen.................  Pendimethalin.
42750-66.......................           42750  Gly Star Ready-To-Use Grass and  Glyphosate-isopropylammonium.
                                                  Weed Killer.

61282-59.......................           61282  DC & R Disinfectant............  Formaldehyde; Alkyl* dimethyl
                                                                                benzyl ammonium chloride
                                                                                *(67%C12, 25%C14, 7%C16,
                                                                                1%C18) & 2-(Hydroxymethyl)-2-
                                                                                nitro-1,3-propanediol.
62719-12.......................           62719  Telone C-17....................  Chloropicrin & Telone.
62719-457......................           62719  Asulam 400.....................  Asulam, sodium salt.
71655-3........................           71655  Sodium Hypochlorite 12.5%......  Sodium hypochlorite.
71655-4........................           71655  Sodium Hypochlorite............  Sodium hypochlorite.
89442-44.......................           89442  Prodiazone Select..............  Prodiamine & Sulfentrazone.
OR-080014......................             400  Comite.........................  Propargite.
OR-080016......................             400  Comite.........................  Propargite.
OR-080017......................             400  Comite.........................  Propargite.
OR-080018......................             400  Comite.........................  Propargite.
OR-080019......................             400  Comite.........................  Propargite.
OR-080026......................           62719  Starane Ultra..................  Fluroxypyr 1-methylheptyl
                                                                                ester.
OR-080031......................             400  Acramite-4SC...................  Bifenazate.
OR-080033......................             400  Dimilin 2L.....................  Diflubenzuron.
TN-130004......................             100  Boundary(R) 6.5EC Herbicide....  Metribuzin & S-Metolachlor.
WA-130011......................            5481  Parazone 3SL Herbicide.........  Paraquat dichloride.
WA-140003......................            5481  Abba Ultra Miticide/Insecticide  Abamectin.
----------------------------------------------------------------------------------------------------------------

    Table 2 of this unit includes the names and addresses of record for
all registrants of the products in Table 1 of this unit, in sequence by
EPA company number. This number corresponds to the first part of the
EPA registration numbers of the products listed in Table 1 of this
unit.

               Table 2--Registrants of Cancelled Products
------------------------------------------------------------------------
           EPA company No.                  Company name and address
------------------------------------------------------------------------
100..................................  Syngenta Crop Protection, LLC,
                                        P.O. Box 18300, Greensboro, NC
                                        27419-8300.
279..................................  FMC Corporation, 2929 Walnut
                                        Street, Philadelphia, PA 19104.
400..................................  Macdermid Agricultural Solutions,
                                        Inc., C/O Arysta LifeScience
                                        North America, LLC, 15401 Weston
                                        Parkway, Suite 150, Cary, NC
                                        27513.
538..................................  The Scotts Company, 14111
                                        Scottslawn Road, Marysville, OH
                                        43041.
1015.................................  Douglas Products and Packaging
                                        Company, LLC, D/B/A Douglas
                                        Products and Packaging, Agent
                                        Name: Pyxis Regulatory
                                        Consulting, Inc., 4110 136th
                                        Street Ct., NW, Gig Harbor, WA
                                        98332.
1043.................................  Steris Corporation, P.O. Box 147,
                                        St. Louis, MO 63166-0147.
2749.................................  Aceto Agricultural Chemicals
                                        Corp., 4 Tri Harbor Court, Port
                                        Washington, NY 11050-4661.
5481.................................  Amvac Chemical Corporation, 4695
                                        Macarthur Court, Suite 1200,
                                        Newport Beach, CA 92660-1706.
19713................................  Drexel Chemical Company, P.O. Box
                                        13327, Memphis, TN 38113-0327.
42750................................  Albaugh, LLC, P.O. Box 2127,
                                        Valdosta, GA 31604-2127.
61282................................  Hacco, Inc., 620 Lesher Place,
                                        Lansing, MI 48912.
62719................................  Dow AgroSciences, LLC, 9330
                                        Zionsville Rd., Indianapolis, IN
                                        46268-1054.
71655................................  BASF Corporation, 100 Park
                                        Avenue, Florham Park, NJ 07932.
89442................................  Prime Source, LLC, Agent Name:
                                        Wagner Regulatory Associates,
                                        Inc., P.O. Box 640, Hockessin,
                                        DE 19707.
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    The Agency received three public anonymous comments on the notice.
For this reason, the Agency does not believe that the comments
submitted during the comment period merit further review or a denial of
the requests for voluntary cancellation

IV. Cancellation Order

    Pursuant to FIFRA section 6(f) (7 U.S.C. 136d(f)), EPA hereby
approves the requested cancellations of the registrations identified in
Table 1 of Unit II. Accordingly, the Agency hereby orders that the
product registrations identified in Table 1 of Unit II are canceled.
The effective date of the cancellations that are the subject of this
notice is August 14, 2019. Any distribution, sale, or use of existing
stocks of the products identified in Table 1 of Unit II in a manner
inconsistent with any of the provisions for disposition of existing
stocks set forth in Unit VI will be a violation of FIFRA.

V. What is the Agency's authority for taking this action?

    Section 6(f)(1) of FIFRA (7 U.S.C. 136d(f)(1)) provides that a
registrant of a pesticide product may at any time request that any of
its pesticide registrations be canceled or amended to terminate one or
more uses. FIFRA further provides that, before acting on the request,
EPA must publish a notice of receipt of any such request in the Federal
Register. Thereafter, following the public comment period, the EPA
Administrator may approve such a request. The notice of receipt for
this action was published for comment in the Federal Register of May
29, 2019 (84 FR 24779) (FRL-9994-18). The comment period closed on June
28, 2019.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action. The existing stocks provisions for the products
subject to this order are as follows.

    The registrants may continue to sell and distribute existing stocks
of products listed in Table 1 of Unit II until August 14, 2019, which
is 1 year after the publication of the Cancellation Order in the
Federal Register. Thereafter, the registrants are prohibited from
selling or distributing products listed in Table 1, except for export
in accordance with FIFRA section 17 (7 U.S.C. 136o), or proper
disposal. Persons other than the registrants may sell, distribute, or
use existing stocks of products listed in Table 1 of Unit II until
existing stocks are exhausted, provided that such sale, distribution,
or use is consistent with the terms of the previously approved labeling
on, or that accompanied, the canceled products.

    Authority:  7 U.S.C. 136 et seq.

    Dated: July 29, 2019.
Delores Barber,
Director, Information Technology and Resources Management Division,
Office of Pesticide Programs.
[FR Doc. 2019-17404 Filed 8-13-19; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register: May 17, 2010 (Volume 75, Number 94)]
[Notices]
[Page 27608-27609]
[DOCID:fr17my10-106]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-62066; File No. SR-NYSEArca-2010-37]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change To Establish Strike
Price Intervals and Trading Hours for Options on Index Linked
Securities

May 10, 2010.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act'') \1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that, on April 28, 2010, NYSE Arca, Inc. (``NYSE Arca'' or the
``Exchange'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to Rule 6.4 Commentary .05 to establish
strike price intervals for options on Index Linked Securities,\3\ and
to amend Rule 7.1 Commentary .02, to establish trading hours for these
products. The text of the proposed rule change is available on NYSE
Arca's Web site at http:// www.nyse.com, on the Commission's Web site
at http://www.sec.gov, and at the Commission's Public Reference Room.
---------------------------------------------------------------------------

    \3\ Index-Linked Securities, also known as exchange-traded
notes, are long-term notes that are the non-convertible debt of an
issuer with a term of at least one year but not greater than thirty
years. These exchange-traded securities are designed for investors
who desire to participate in a specific market segment by providing
exposure to one or more identifiable underlying securities,
commodities, currencies, derivative instruments or market indexes.
The Exchange's listing standards for options on Index-Linked
Securities were established in July 2008. See Securities Exchange
Act Release No. 58203 (July 22, 2008), 73 FR 43812 (July 28, 2008)
(SR-NYSEArca-2008-57). Other Exchanges have established similar
listing standards. See Securities Exchange Act Release Nos. 58571
(September 17, 2008), 73 FR 55188 (September 24, 2008) (SR-Phlx-
2008-60) (notice of filing and immediate effectiveness); 59923 (May
14, 2009), 74 FR 23902 (May 21, 2009) (SR-NASDAQ-2009-046) (notice
of filing and immediate effectiveness); 58204 (July 22, 2008), 73 FR
43807 (July 28, 2008) (SR-CBOE-2008-64) (approval order); and 58985
(November 20, 2008), 73 FR 72538 (November 28, 2008) (SR-ISE-2008-
86) (notice of filing and immediate effectiveness).
---------------------------------------------------------------------------

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of this filing is to amend Rule 6.4 Commentary .05 and
Rule 7.1 Commentary .02 to establish strike price intervals and trading
hours for options on Index-Linked Securities (``ILS''), also known as
Exchange-Traded Notes (``ETN''), prior to the Exchange actually listing
and trading these products.
    The Commission has approved the Exchange's proposal, as well as the
proposals of other options exchanges, to enable the listing and trading
of options on ILS (ETN).\4\ Options trading has not commenced to date
and is contingent upon the Commission's approval of The Options
Clearing Corporation's (``OCC'') proposed supplement to the Options
Disclosure Document (``ODD'') that will provide disclosure regarding
options on Index-Linked Securities.\5\
---------------------------------------------------------------------------

    \4\ See supra Note 3.
    \5\ OCC previously received Commission approval to clear options
based on Index-Linked Securities. See Securities Exchange Act
Release No. 60872 (October 23, 2009), 74 FR 55878 (October 29, 2009)
(SR-OCC-2009-14) (approval order).
---------------------------------------------------------------------------

$1 Strikes for ILS (ETN) Options
    Prior to the commencement of trading options on Index-Linked
Securities, the Exchange is proposing to establish that strike price
intervals of $1 will be permitted where the strike price is less than
$200. Where the strike price is greater than $200, $5 strikes will be
permitted. These proposed changes are reflected by the addition to
Commentary .05 to Rule 6.4.
    The Exchange is seeking to establish $1 strikes for ILS (ETN)
options where the strike price is less than $200 because the Exchange
believes the marketplace and investors will be expecting these types of
options to trade in a similar manner to options on exchange-traded
funds (``ETFs''). Strike prices for ETF options are permitted in $1 or
greater intervals where the strike price is $200 or less and $5 or
greater where the strike price is greater than $200. Accordingly, the
Exchange believes that the rationale for permitting $1 strikes for ETF
options equally applies to permitting $1 strikes for ILS (ETN) options,
and that investors will be better served if $1 strike price intervals
are available for ILS (ETN) options where the strike price is less than
$200. The Exchange believes that $1 strike price intervals for options
on Index-Linked Securities will provide investors with greater
flexibility by allowing them to establish positions that are better
tailored to meet their investment objectives.
Trading Hours for ILS (ETN) Options
    The Exchange proposes to amend Commentary .02 to Rule 7.1 to
provide that options on exchange-traded notes including Index-Linked
Securities may be traded on the Exchange until 1:15 p.m. (Pacific Time)
each business day. This will establish similar trading hours for ILS
(ETN) options as the currently-established trading hours for ETF
options.
    The Exchange expects that other option exchanges that have adopted
rules providing for the listing and trading of options on Index-Linked
Securities has or will submit similar proposals.\6\
---------------------------------------------------------------------------

    \6\ See, for example, Securities Exchange Act Release No. 61466
(February 2, 2010), 75 FR 6243 (February 8, 2010) (SR-CBOE-2010-005)
(notice of filing).
---------------------------------------------------------------------------

    The Exchange has analyzed its capacity and believes the Exchange
and the Options Price Reporting Authority (``OPRA'') have the necessary
systems capacity to handle the additional traffic associated with the
listing and trading of $1 strikes where the strike price is less than
$200 for ILS (ETN) options.
2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
Section 6(b) \7\ of the Securities Exchange Act of 1934 (the ``Act''),
in general, and furthers the objectives of Section 6(b)(5) \8\ in
particular in that it is designed to promote just and equitable
principles of trade, to prevent fraudulent and manipulative acts, to
remove

impediments to and to perfect the mechanism for a free and open market
and a national market system by having strike price intervals and
trading hours established prior to the commencement of trading in
options on Index-Linked Securities and thereby lessening the likelihood
for investor confusion.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78f(b).
    \8\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the foregoing proposed rule change: (i) Does not
significantly affect the protection of investors or the public
interest; (ii) does not impose any significant burden on competition;
and (iii) by its terms, does not become operative for 30 days from the
date on which it was filed, or such shorter time as the Commission may
designate, if consistent with the protection of investors and the
public interest, it has become effective pursuant to Section
19(b)(3)(A) of the Act \9\ and Rule 19b-4(f)(6) thereunder.\10\
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(3)(A).
    \10\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires the self-regulatory organization to submit to the
Commission written notice of its intent to file the proposed rule
change, along with a brief description and text of the proposed rule
change, at least five business days prior to the date of filing of
the proposed rule change, or such shorter time as designated by the
Commission. The Exchange has satisfied this requirement.
---------------------------------------------------------------------------

    The Exchange has asked the Commission to waive the 30-day operative
delay so that the proposal may become operative immediately upon
filing. The Commission believes that doing so is consistent with the
protection of investors and the public interest. The Commission notes
that it recently approved the same changes to strike price intervals
and trading hours for options on Index-Linked Securities for another
exchange.\11\ The Commission believes that the proposed changes to
strike price intervals and trading hours for options on Index-Linked
Securities do not raise any novel regulatory issues, and waiver of the
operative delay should benefit investors by creating consistency and
predictability for investors who may view these products as serving
similar investment functions in the marketplace to ETFs. Therefore, the
Commission designates the proposal operative upon filing.\12\
---------------------------------------------------------------------------

    \11\ See Securities Exchange Act Release Nos. 61696 (March 12,
2010), 75 FR 13174 (March 18, 2010) (SR-CBOE-2010-005); 61943 (April
20, 2010), 75 FR 21689 (April 26, 2010) (SR-Phlx-2010-40).
    \12\ For purposes only of waiving the operative delay for this
proposal, the Commission has considered the proposed rule's impact
on efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NYSEArca-2010-37 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2010-37. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/
rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for Web site
viewing and printing in the Commission's Public Reference Room, 100 F
Street, NE., Washington, DC 20549, on official business days between
the hours of 10 a.m. and 3 p.m. Copies of such filing also will be
available for inspection and copying at the principal office of the
Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
NYSEArca-2010-37 and should be submitted on or before June 7, 2010.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\13\
---------------------------------------------------------------------------

    \13\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Elizabeth M. Murphy,
Secretary.
[FR Doc. 2010-11651 Filed 5-14-10; 8:45 am]
BILLING CODE 8010-01-P


[Federal Register Volume 88, Number 236 (Monday, December 11, 2023)]
[Notices]
[Page 85937]
[FR Doc No: 2023-27148]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[SEC File No. 270-462, OMB Control No. 3235-0521]

Submission for OMB Review; Comment Request; Extension: Rule 425

Upon Written Request Copies Available From: Securities and Exchange
Commission, Office of FOIA Services, 100 F Street NE, Washington, DC
20549-2736

    Notice is hereby given that, pursuant to the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') has submitted to the Office of Management
and Budget this request for extension of the previously approved
collection of information discussed below.
    Rule 425 (17 CFR 230.425) under the Securities Act of 1933 (15
U.S.C. 77a et seq.) requires the filing of certain prospectuses and
communications under Rule 135 (17 CFR 230.135) and Rule 165 (17 CFR
230.165) in connection with business combination transactions. The
purpose of the rule is to permit more oral and written communications
with shareholders about tender offers, mergers and other business
combination transactions on a more-timely basis, so long as the written
communications are filed on the date of first use. The information
provided under Rule 425 is made available to the public upon request.
Also, the information provided under Rule 425 is mandatory.
Approximately 7,160 issuers file communications under Rule 425 at an
estimated 0.25 hours per response for a total of 1,790 annual burden
hours (0.25 hours per response x 7,160 responses).
    An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid control number.
    The public may view background documentation for this information
collection at the following website: www.reginfo.gov. Find this
particular information collection by selecting ``Currently under 30-day
Review--Open for Public Comments'' or by using the search function.
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
by January 10, 2024 to (i) www.reginfo.gov/public/do/PRAMain and (ii)
David Bottom, Director/Chief Information Officer, Securities and
Exchange Commission, c/o John Pezzullo, 100 F Street NE, Washington, DC
20549, or by sending an email to: [email protected].

    Dated: December 6, 2023.
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2023-27148 Filed 12-8-23; 8:45 am]
BILLING CODE 8011-01-P


<EPA Registration Division contact: [BeWanda Alexander, Insecticide
Branch,<PHONE_NUMBER>]>

 <[BASF Corporation]>

<[EPA-HQ-OPP-2010-0234]>

<	EPA has received a pesticide petition 0F7690 from [BASF Corporation],
[26 Davis Drive, P.O. Box 13528, Research Triangle Park, North Carolina
27709-3528] proposing, pursuant to section 408(d) of the Federal Food,
Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part
180. by establishing a tolerance for residues of combined residues of
alpha-cypermethrin and cypermethrin (including zeta-cypermethrin)(
(S)-α-cyano-3-phenoxybenzyl
(1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate and
(R)-α-cyano-3-phenoxybenzyl
(1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate)] in
or on the raw agricultural commodity [tree nuts (group 14), dried
shelled pea and bean, except soybean (subgroup 6C), corn grain, pop
corn, sweet corn, soybeans and sugar beet roots] at [0.05] parts per
million (ppm) and commodity [succulent shelled pea and bean (subgroup
6B) and root and tuber vegetables (group 1)] at [0.1] parts per million
(ppm) and commodity [cucurbit vegetables (group 9), fruiting vegetables
(group 8), sugar beet tops and wheat grain] at [0.2] parts per million
(ppm) and commodity [citrus fruit (group 10] at [0.35] parts per million
(ppm) and commodity [cottonseed, edible podded legume vegetable
(subgroup 6A) and sorghum grain] at [0.5] parts per million (ppm) and
commodity [rice grain] at [1.5] parts per million (ppm). and commodity
[citrus dried pulp] at [1.8] parts per million (ppm) and commodity [head
and stem brassica (subgroup 5A)] at [2.0] parts per million (ppm) and
commodity [citrus oil] at [4.0] parts per million (ppm) and commodity
[leafy vegetable, except brassica (group 4)] at [10] parts per million
(ppm) and commodity [alfalfa hay] at [15] parts per million (ppm)...
EPA has determined that the petition contains data or information
regarding the elements set forth in section 408 (d)(2) of  FDDCA;
however, EPA has not fully evaluated the sufficiency of the submitted
data at this time or whether the data supports granting of the petition.
Additional data may be needed before EPA rules on the petition.>

Cypermethrin is a pyrethroid insecticide consisting of three asymmetric
carbon atoms, and therefore, 8 stereo-isomeric mixtures.  Cypermethrin
is also characterized as consisting of cis- and trans-configured
diastereo-isomeric components based on orientation around its
cyclopropane ring.  Zeta-cypermethrin and alpha-cypermethrin are
optimized stereo-isomeric mixtures of cypermethrin, each consisting of 4
major components. These zeta-cypermethrin and alpha-cypermethrin
components are the enriched trans- (alpha-S) and cis (cis2-R) isomeric
orientations of cypermethrin, respectively.

<A. Residue Chemistry>

<	1. Plant metabolism.[The metabolism of cypermethrin in plants is
adequately understood.  Studies that have been conducted to determine
the metabolism of radiolabelled cypermethrin in various crops all
produced similar results.  The residue of concern is the parent compound
only.]>

<	2. Analytical method. [There is a practical analytical method for
detecting and measuring levels of cypermethrin in or on food with a
limit of detection that allows monitoring of food with residues at or
above the levels set in these tolerances (Gas Chromatography with
Electron Capture Detection or GC/ECD and LC/MS/MS methods are
available).]

>

<	3. Magnitude of residues. [Alpha-cypermethrin registration will cite
the applicable magnitude of the residue studies conducted for the
registration of zeta-cypermethrin.  Field trials with zeta-cypermethrin
were carried out to determine the magnitude of the residue in/on root
and tuber vegetables (group 1), leafy vegetables (group 4), head and
stem brassica (subgroup 5A), edible podded legume vegetable (subgroup
6A), succulent shelled pea and bean (subgroup 6B), dried shelled pea and
bean (subgroup 6C), fruiting vegetables (group 8), cucurbit vegetables
(group 9), citrus fruit (group 10), tree nuts (group 14), field corn,
pop corn, sweet corn, wheat grain, rice grain, sorghum, sugar beets,
soybeans, cotton and alfalfa. The number and locations of field trials
are in accordance with OPPTS Guideline 860.1500. Field trials were
carried out using the maximum label rates, the maximum number of
applications, and the minimum pre-harvest interval (PHI) for all the
crops. Detected residues of cypermethrin in all crops support the
proposed tolerances.]>

<B. Toxicological Profile>

<	1. Acute toxicity.   [Acute toxicity studies conducted with
alpha-cypermethrin show a low toxicity via the oral (category III),
dermal (category III) and inhalation (category IV) exposure routes.
Alpha-cypermethrin is not irritating to the eyes and is not a skin
sensitizer.  However, it is mildly irritating to the skin.  The acute
toxicity of alpha-cypermethrin EC formulation is attenuated following
acute exposures via inhalation and dermal routes.  The EC formulation is
a skin and eye irritant, mild skin sensitizer and has moderate toxicity
via oral exposure route. ]>

<	2. Genotoxicty.  [Alpha-cypermethrin was negative for inducing
mutations in both in vitro Ames and an in vitro CHO/HGPRT locus
mammalian cell mutation assays.   Alpha-cypermethrin caused no increase
in the incidence of chromatid or chromosome aberrations or polyploidy in
bone marrow cells following per os in-vivo exposure to Wistar rats.
Similarly, Alpha-cypermethrin did not increase the frequency of
chromatid gaps, chromatid breaks or total chromatid aberrations in rat
liver (RL4) cell cultures.  >Alpha-cypermethrin did not produce any
detectable DNA single-strand damage using alkaline elution profiles of
liver DNA.

From the all available data on alpha-cypermethrin, it can be concluded
that this compound is non-mutagenic in tests with Salmonella
typhimurium, Saccharomyces cerevisiae, and in-vivo and in-vitro tests
with rat liver cells for the induction of chromosome aberration and
production of DNA single-strand damage.  Overall, the weight of the
evidence demonstrates that alpha-cypermethrin is not genotoxic. ]

	3. Reproductive and developmental toxicity.  [The reproductive and
developmental toxicity of alpha-cypermethrin was investigated in a
2-generation rat reproduction study as well as in rat and rabbit
developmental toxicity studies. The test substance in these studies was
either alpha-cypermethrin or zeta-cypermethrin – the same racemic
pyrethroid mixture with similar enantiomeric composition.

In the rat multigeneration study conducted with zeta-cypermethrin,
another related pyrethroid racemate mixture, the test substance was
administered via diet at levels of 0, 7.5, 25, 100, 375 or 750 ppm,
equivalent to 0, 0.5, 1.8, 7, 27 or 45 mg/kg/day.  Clinical signs of
neurotoxicity and isolated incidences of mortality were observed in the
parental animals at the top dose of 45 mg/kg/day.  An increased
incidence of pup mortality was also seen at 45 mg/kg/day.  At 27
mg/kg/day, decreased body weight gain, especially during lactation, and
increased relative brain weights were observed in male and female adult
animals.  Decreased body weight gain during lactation was also seen
among offspring at 27 mg/kg/day.  The NOAEL for parental and systemic
toxicity was 100 ppm, equivalent to 7 mg/kg body weight per day.
Similarly, the NOAEL for offspring toxicity was 100 ppm, equivalent to 7
mg/kg/day.

Developmental toxicity studies, via gavage exposures, were conducted in
rats and rabbits with alpha-cypermethrin.  In these studies, there was
no evidence of teratogenicity in animals treated during the phase of
organogenesis.

In rabbits (0, 3, 15 or 30 mg/kg/day via gavage in corn oil vehicle),
reduced maternal food consumption and body weights were observed at 30
mg/kg/day; no treatment-related effects on fetal weights were observed.
The NOAEL for maternal toxicity and embryotoxicity was 15 mg/kg/day and
30 mg/kg/day, respectively.  There were no indications for
teratogenicity.

Administration of alpha-cypermethrin via gavage at 0, 3, 9, or 18
mg/kg/day to pregnant rats during fetal organogenesis (gestational days
6-15) elicited maternal toxicity at the two top doses, characterized by
changes in clinical conditions and reduction in food consumption and
body weight gain. Due to marked clinical signs of toxicity the dose
level of 18 mg/kg/ day was lowered to 15 mg/kg/day on day 10 of
gestation.  Females at 18 or 15 mg/kg/day showed unsteady gait,
piloerection, and other signs of maternal toxicity. Slight body weight
reductions were also seen in the females at 9 mg/kg/day. A slight
reduction in fetal weights was observed at these dose levels (9, 15/18
mg/kg/day) in concert with maternal toxicity.  There was no indication
for teratogenicity. The NOAEL for maternal and fetal toxicity was 9
mg/kg/day.

In the rat developmental toxicity study, the maternal and developmental
NOAEL was 9 mg/kg/day.  For rabbits, the NOAEL for systemic toxicity was
15 mg/kg/day, and the NOAEL for developmental toxicity was 30 mg/kg/day,
the highest dose tested. ]

<	4. Subchronic toxicity. [A similar toxicity profile was observed
across rats, mice and dogs following subchronic exposure to
alpha-cypermethrin. These profiles are mostly related to the mode of
action of alpha-cypermethrin and include effects on the neuromuscular
system.  Typical indicator effects for this mode of action were observed
and included tremors, gait abnormalities, decreased motor activity and
increased salivation.  Surviving animals recovered within 3 -7 days.
The short term and reversible nature of these neurotoxic effects is in
line with studies showing that type II pyrethroids such as
alpha-cypermethrin can cause exaggerated pharmacological effects at high
dose levels that do not result in histopathologic lesions on nervous
system tissues.

In rats, clinical signs characteristic for pyrethroid neurotoxicity were
observed in short-term toxicity studies (4-6 weeks) at ≥800 ppm.
Clinical signs were more pronounced in males and included high stepping,
splayed gait, abasia and hypersensitivity. Further observed effects
comprised decreased food intake and body weights, and some hematological
findings at ≥400 ppm.  The NOEL was 200 ppm, equivalent to 10
mg/kg/day.  After dietary administration at 540 ppm for 90 days,
abnormal gait with splayed hind limbs in male rats and decreased food
intake and body weights were observed. No other treatment-related
effects occurred during the course of this study.  The NOEL was 60 ppm,
equivalent to 3 mg/kg/day.

 after dietary administration of alpha-cypermethrin at ≥800 ppm for 4
weeks. The death of two animals and neurological signs of toxicity were
associated with administration of alpha-cypermethrin at 1200 or 1600
ppm.  The NOEL was 400 ppm, equivalent to 57 mg/kg/day.  In a 90-day
dietary exposure toxicity study in mice, un-groomed coat, hair loss and
encrustations on the dorsal surface, reduced body weights, and increased
aspartate aminotransferase activity were observed at 250 ppm.   The NOEL
was <50 ppm, equivalent to <7.1 mg/kg/day, based on hair loss seen at
the lowest dose tested.

In dogs, clinical signs including body tremors, head nodding, ataxia,
agitation, lip licking, subdued behavior and high stepping gait were
observed at the top dose level (270 ppm) of a 90-day dietary toxicity
study. No other treatment-related effects were observed after
administration of alpha-cypermethrin to dogs.  The NOEL was 90 ppm,
equivalent to 2.25 mg/kg/day.

The neurotoxic potential of alpha-cypermethrin was studied following
acute oral exposure in the rat.  The subchronic neurotoxicity potential
of alpha-cypermethrin was also investigated in the rat, using
zeta-cypermethrin as a surrogate test material.

In the acute neurotoxicity study, no deaths or adverse clinical or
pathological treatment-related effects were observed after oral
administration of alpha-cypermethrin at 4 mg/kg body weight. At 20 and
40 mg/kg body weight, clinical signs of neurotoxicity (including
abnormal gait, piloerection, hunched posture, and diarrhea), and
significant differences to the controls in functional observation
battery tests were observed, with females exhibiting reduced
susceptibility.  The NOEL was 4 mg/kg.

No evidence of increased neurotoxicity was observed in the subchronic
neurotoxicity study with zeta-cypermethrin. Clinical signs of toxicity
were similar to acute exposure and included decreased motor activity,
decreased body weight gains and food consumption.  The NOAEL was 5 and
31 mg/kg/day in males and females, respectively.  Overall, the
neurotoxic effects elicited by alpha-cypermethrin were reversible. ]

>

<	5. Chronic toxicity.  [The results of long-term oral exposure studies
indicate that alpha-cypermethrin is not carcinogenic in mice or rats.
At high doses in long term oral exposure studies with rats, mice and
dogs, observations demonstrate evidence of slight neurologic signs and
decreased body weight gains.  This is consistent with the mechanism of
action of alpha-cypermethrin on the peripheral and central nervous
system, through interactions with sodium channels.  The NOAEL in the
mouse oncogenicity study was 30 ppm, equivalent to 3 mg/kg body
weight/day in males and 3.5 mg/kg body weight/day in females.  In the
rat chronic/oncogenicity study, the NOAEL was 100 ppm, equivalent to 5
mg/kg body weight/day in males and females.   In a chronic (1-year) dog
study, the NOAEL was 60 ppm, equivalent to 2 mg/kg/day in males and 2.2
mg/kg/day in females. ]>

<	6. Animal metabolism. [The metabolism of cypermethrin in animals is
adequately understood.  Cypermethrin is rapidly absorbed, distributed,
and excreted in rats when administered orally.  Biotransformation is
principally governed by hydrolytic and oxidation reactions. ] >

<	7. Metabolite toxicology [No metabolites of toxicological concern were
identified with alpha-cypermethrin. ]>

<	8. Endocrine disruption. [No specific tests have been conducted with
alpha-cypermethrin to determine whether the chemical may have an effect
in humans that is similar to an effect produced by a naturally occurring
estrogen or other endocrine effects.  However, there were no significant
findings in other relevant toxicity studies (e.g., sub-chronic and
chronic toxicity, developmental toxicity and multi-generation
reproductive studies) which would suggest that alpha-cypermethrin
produces any endocrine disruption. ]

>

<C. Aggregate Exposure>

<	1. Dietary exposure. [Exposure assessments were conducted to evaluate
the potential risk due to acute and chronic dietary exposure of the U.S.
population and sub-populations to residues of Alpha-Cypermethrin.
Alpha-cypermethrin is an isomer of cypermethrin.  Zeta-cypermethrin is
also an isomer of cypermethrin.  When the EPA conducted the risk
assessment for zeta-cypermethrin (November 27, 2007, D335224,  Dennis
McNeilly), EPA included all uses for cypermethrin and zeta-cypermethrin
together in the exposure and risk assessment because of the close
similarity in toxicity and chemical characteristics.   The EPA exposure
and risk assessment for alpha-cypermethrin will be approached similarly
and the exposure assessment and risk evaluation will include the uses
from all three active ingredients (cypermethrin, zeta-cypermethrin,
alpha-cypermethrin).  Alpha-cypermethrin will not be registered on any
crops where zeta-cypermethrin or cypermethrin are not currently
registered.  However, alpha-cypermethrin will not be registered on all
the current crops registered with zeta-cypermethrin or cypermethrin.
Also, the application rate and seasonal maximum rate for
alpha-cypermethrin will be less than cypermethrin and zeta-cypermethrin.
  This analysis includes all the current existing tolerances for
cypermethrin/zeta-cypermethrin 40 CFR 180.418.   ]>

<Food. [

.

Acute Dietary Exposure Assessment

The EPA conducted a highly refined probabilistic acute dietary exposure
assessment in the “Reregistration Eligibility Decision for
Cypermethrin (revised 01/14/2008)” using PDP data, percent crop
treated information and processing factors.  This refined acute dietary
exposure estimates are applicable to alpha-cypermethrin.  The only
difference between alpha-cypermethrin and cypermethrin are in the acute
population adjusted dose (aPAD).  The aPAD for cypermethrin is based on
a NOAEL of 10 mg/kg bw/day with a 100x uncertainty factor and a 1x FQPA
SF to give a aPAD of 0.1 mg/kg bw/day. The aPAD for alpha-cypermethrin
is based on a NOAEL of 4 mg/kg bw/day with a 100x uncertainty factor and
a 1x FQPA SF to give a aPAD of 0.04 mg/kg bw/day.

In the cypermethrin assessment, the most highly exposed population
subgroup was children 1-2 years old at 6.1% of the aPAD at the 99.9th
percentile of exposure.   The aPAD for cypermethrin is 0.1 mg/kg bw/day
and an exposure of 6.1% aPAD is a food exposure of 0.0061 mg/kg bw/day.
Using the same acute food exposure for alpha-cypermethrin,  the most
highly exposed population subgroup was children 1-2 years old at 15.3 %
of the aPAD at the 99.9th percentile of exposure.   The results of the
analysis show that the estimated food exposures are well below the
Agency's level of concern (< 100% aPAD).

Chronic Dietary Exposure Assessment

The chronic dietary exposure estimates cited in this document are from
the most recent dietary assessment conducted for
zeta-cypermethrin/cypermethrin by EPA (November 5, 2007, D335224, Dennis
McNeilly).  In this dietary assessment, EPA used anticipated residues,
crop treated factors, residue data from PDP.  For commodities without a
registered use or tolerance for cypermethrin/zeta-cypermethrin, EPA
assumed these commodities would be treated in a food handling
establishment (100% treated) and an anticipated residues of ½ the LOD
(0.05 ppm) was assumed for all these commodities.

Alpha-cypermethrin registration will cite all the environmental fate
studies done for the registration of zeta-cypermethrin and cypermethrin.
 Therefore, the drinking water assessment conducted for the
zeta-cypermethrin assessment is used for this alpha-cypermethrin
exposure assessment.   The chronic surface water value used in this
assessment is 0.013 ppb (February 8, 2007, D334937, J. Melendez).

The chronic Population Adjusted Dose (cPAD) used for U.S. population and
all sub-populations is 0.015 mg/kg bw/day. This endpoint is based on the
NOAEL value of 1.5 using a FQPA safety factor of 1.  The most highly
exposed population sub-group was children 1-2 years of age which
utilized 10.0 % cPAD.  The results of the chronic dietary assessment are
presented in Table1.

Table 1. Results for Alpha-Cypermethrin Chronic Dietary Exposure
Analysis including Food and Drinking Water Exposure.

Population	Exposure Estimate	%cPAD

Subgroups	(mg/kg b.w./day)

U.S. Population	0.000454	3.0

All Infants (< 1 year old)	0.000943	6.3

Children (1-2 years old)	0.001496	10.0

Children (3-5 years old)	0.001176	7.8

Children (6-12 years old)	0.00063	4.2

Youth (13-19 years old)	0.000286	1.9

Adults (20-49 years old)	0.000333	2.2

Adults (50+ years old)	0.000415	2.8

Females (13-49 years old)	0.000344	2.3

The results of the analysis show that for all populations, the exposures
are below a level of concern (< 100% cPAD).  ]>

<Drinking water.

[ Alpha-cypermethrin will not be registered on any crops where
zeta-cypermethrin or cypermethrin are not currently registered.
However, alpha-cypermethrin will not be registered on all the current
crops registered with zeta-cypermethrin or cypermethrin.

Alpha-cypermethrin registration will cite all the environmental fate
studies done for the registration of zeta-cypermethrin and cypermethrin.
 Therefore, the drinking water assessment conducted for the
zeta-cypermethrin assessment is used for this alpha-cypermethrin
exposure assessment.   The acute surface water value used in this
assessment is   1.0 ppb (February 8, 2007, D334937, J. Melendez).   The
chronic surface water value used in this assessment is 0.013 ppb
(February 8, 2007, D334937, J. Melendez).  The acute and chronic
groundwater EDWC value is 0.0036 ppb (February 8, 2007, D334937, J.
Melendez).

Acute Aggregate Exposure and Risk (food and water)

The aggregate acute risk including exposure of Alpha-Cypermethrin from
food and water are done for the most highly exposure subpopulation,
children 1-2 years old.  The food exposure is 0.0061 mg/kgbw/day and the
drinking water exposure using a EDWC of 1.00 ppb is 0.000199 mg/kg
bw/day   The combined exposure is 0.006299 mg/kgbw/day which accounts
for 15.7% of the aPAD.  The results demonstrate that there are no safety
concerns for any subpopulation based on the proposed uses and the
results meet the FQPA standard of reasonable certainty of no harm.

Short- and Intermediate-Term Aggregate Exposure and Risk (food, water,
and residential)

Short- and intermediate-term aggregate risk assessments include chronic
exposure from food, water, and exposure from residential uses.  The
exposure values used in this aggregate assessment are from the recent
human health assessment for Zeta-cypermethrin conducted by EPA (D.
McNally, November 27, 2007, D344749).  BASF will cite the data from
zeta-cypermethrin for the alpha-cypermethrin registration.  The short-
and intermediate-term endpoint is 7.4 mg/kg bw/day.  The aggregate
assessment was conducted for the most highly exposure population group,
children 1-2 years old.  The highest residential oral exposure for
children 1-2 was for hand-to-mouth activity from indoor surfaces
following crack and crevice treatment.  This is the highest residential
oral exposure so it is protective for all other scenarios.  The highest
dermal residential exposure for children 1-2 years old occurred from the
indoor treatment of hard wood and carpets.  This dermal exposure is
protective for all other scenarios.  The short- and intermediate-term
aggregate exposure for children 1-2 is shown in Table 2.

Table 2.  Aggregate Short- and Intermediate-term Aggregate Exposure for
Children 1-2 years old.

Food exposure (mg/kg bw/day)	MOE	Oral carpet (mg/kg bw/day)	MOE	Dermal
Carpet (mg/kg bw/day)	MOE	Aggregate MOE

0.001496	4947	0.01111	666	0.0336	220	160

The assessment shows that the short- and intermediate-term aggregate
exposure is below the EPA level of concern.

Chronic Aggregate Exposure and Risk (food and water)

The aggregate chronic risk including exposure of Alpha-Cypermethrin from
food and water are shown in Table 1. The results demonstrate there are
no safety concerns for any subpopulation based on the proposed uses and
the results meet the FQPA standard of reasonable certainty of no harm.

]>

<	2. Non-dietary exposure. [The residential exposure cited in this
assessment is based on the most recent exposure assessment cited for
cypermethrin / zeta-cypermethrin (D. McNally, November 27, 2007,
D344749).   The residential post-application incidental oral exposure
MOE’s range from 190 to 960,000 which exceed the target MOE of 100
(D334263; Nov. 29, 2006, Zeta-cypermethrin: Revised Human Health risk
assessment).  The combined exposure to toddlers following home lawn
application, hand to mouth, object to mouth, and incidental soil
ingestion was 2,600 which greatly exceeds the target MOE.  The dermal
exposure for adults is not assessed because there is no dermal NOAEL
selected for adults.  The dermal exposure for toddlers was determined
and the calculated MOEs were all greater than the target MOE (D.
McNally, November 27, 2007, D344749).  This assessment shows that there
are no levels of concern which are exceeded from the residential uses.]>

<D. Cumulative Effects>

<	["Section 408(b)(2)(D)(v) requires that, when considering whether to
establish, modify, or revoke a tolerance, the Agency consider
“available information'' concerning the cumulative effects of a
particular pesticide's residues and “other substances that have a
common mechanism of toxicity." Alpha-cypermethrin is a member of the
pyrethroid class of pesticides. Although all pyrethroids alter nerve
function by modifying the normal biochemistry and physiology of nerve
membrane sodium channels, EPA is not currently following a cumulative
risk approach based on a common mechanism of toxicity for the
pyrethroids.  Although all pyrethroids interact with sodium channels,
there are

multiple types of sodium channels and it is currently unknown whether
the pyrethroids have similar effects on all channels. Nor do we have a
clear understanding of effects on key downstream neuronal function e.g.,
nerve excitability, nor do we understand how these key events interact
to produce their compound-specific patterns of neurotoxicity.  There is
ongoing research by the EPA's Office of Research and Development and
pyrethroid registrants to evaluate the differential biochemical and
physiological actions of pyrethroids in mammals. When available, the
Agency will consider this research and make a determination of common
mechanism as a basis for assessing cumulative risk.]

>

<E. Safety Determination>

<	1. U.S. population. [Based on this risk assessment, BASF concludes
that there is a reasonable certainty that no harm will result to the
general population from the aggregate exposure to Alpha-cypermethrin
from the proposed uses.]>

<	2. Infants and children. [Based on this risk assessment, BASF
concludes that there is a reasonable certainty that no harm will result
to infants or children from the aggregate exposure to Alpha-cypermethrin
from the proposed uses.]>

<F. International Tolerances>

"

3

4

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

4

C

L

W

X

\

a

ˆ

‰

æ

ç

ë

ð

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

>*B*

B*

h

B*

h

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

B*

>*B*

B*

B*

B*

B*

CODEX maximum residue levels established for cypermethrin residues in
many different crop and crop groups.  JMPR considered the residue trials
for alpha-cypermethrin, zeta-cypermethrin and cypermethrin collectively.
 Codex maximum residue levels have been established in the following
crops:

Leafy vegetables			0.7	Edible offal, mammalian		0.05

Pome fruits				0.7	Meat, from mammals		2.0

Stone fruits				2.0	Poultry meat				0.05

Roots and tubers			0.01	Eggs					0.01

Fruiting vegetables, cucurbits	0.07	Milks					0.05

Legume vegetables			0.7	Milk fats 				0.5

Pulses					0.05

Dry bean				0.05

Brassica				1.0

Leafy vegetables			0.7

Citrus fruits				2.0

Cereal grains				0.3

Corn, sweet				0.05

Oilseed				0.1

Eggplant				0.03

Okra					0.5

Onion bulb				0.01

Bell pepper				0.1

Non-bell pepper			2.0

Pimentos				0.1

Sugar beet 				0.1

Sugar cane				0.2

Tomato				0.2]>

 PAGE

 PAGE   7


[Federal Register Volume 86, Number 244 (Thursday, December 23, 2021)]
[Notices]
[Pages 72957-72958]
[FR Doc No: 2021-27787]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP22-27-000]

Gas Transmission Northwest LLC; Notice of Request Under Blanket
Authorization and Establishing Intervention and Protest Deadline

    Take notice that on December 6, 2021, Gas Transmission Northwest
LLC (GTN) filed a prior notice request for authorization, in accordance
with 18 CFR Sections 157.205, 157.208 and 157.210 of the Federal Energy
Regulatory Commission's (Commission) regulations under the Natural Gas
Act and GTN's blanket certificate issued in Docket Nos. CP82-530-000,
et al., to conduct hydrostatic testing along it's A-Line and
subsequently restore its original Maximum Allowable Operating Pressure
of those sections located in Boundary and Bonner Counties, Idaho. GTN
states that the proposed testing will have no impact on GTN's existing
customers. GTN states that the restored MAOP will alleviate operational
constraints and improve line pack management, which will ultimately
improve reliability and flexibility of GTN's system. GTN estimates that
the cost of the Project is approximately $22 million. GTN states that
the proposed MAOP restoration will not change available capacity on
GTN's system, all as more fully set forth in the request which is on
file with the Commission and open to public inspection.
    In addition to publishing the full text of this document in the
Federal Register, the Commission provides all interested persons an
opportunity to view and/or print the contents of this document via the
internet through the Commission's Home Page (http://ferc.gov) using the
``eLibrary'' link. Enter the docket number excluding the last three
digits in the docket number field to access the document. At this time,
the Commission has suspended access to the Commission's Public
Reference Room, due to the proclamation declaring a National Emergency
concerning the Novel Coronavirus Disease (COVID-19), issued by the
President on March 13, 2020. For assistance, contact the Federal Energy
Regulatory Commission at [email protected] or call toll-free,
(886) 208-3676 or TYY,<PHONE_NUMBER>.
    Any questions concerning this application should be directed to
David A. Alonzo, Manager, Project Authorizations, Gas Transmission
Northwest LLC, 700 Louisiana Street, Suite 1300, Houston, Texas 77002-
2700, at<PHONE_NUMBER>; or email at [email protected].
    Pursuant to Section 157.9 of the Commission's Rules of Practice and
Procedure,\1\ within 90 days of this Notice the Commission staff will
either: Complete its environmental review and place it into the
Commission's public record (eLibrary) for this proceeding; or issue a
Notice of Schedule for Environmental Review. If a Notice of Schedule
for Environmental Review is issued, it will indicate, among other
milestones, the anticipated date for the Commission staff's issuance of
the final environmental impact statement (FEIS) or environmental
assessment (EA) for this proposal. The filing of an EA in the
Commission's public record for this proceeding or the issuance of a
Notice of Schedule for Environmental Review will serve to notify
federal and state agencies of the timing for the completion of all
necessary reviews, and the subsequent need to complete all federal
authorizations within 90 days of the date of issuance of the Commission
staff's FEIS or EA.
---------------------------------------------------------------------------

    \1\ 18 CFR (Code of Federal Regulations) 157.9.
---------------------------------------------------------------------------

Public Participation

    There are three ways to become involved in the Commission's review
of this project: You can file a protest to the project, you can file a
motion to intervene in the proceeding, and you can file comments on the
project. There is no fee or cost for filing protests, motions to
intervene, or comments. The deadline for filing protests, motions to
intervene, and comments is 5:00 p.m. Eastern Time on February 14, 2022.
How to file protests, motions to intervene, and comments is explained
below.

Protests

    Pursuant to section 157.205 of the Commission's regulations under
the NGA,\2\ any person \3\ or the Commission's staff may file a protest
to the request. If no protest is filed within the time allowed or if a
protest is filed and then withdrawn within 30 days after the allowed
time for filing a protest, the proposed activity shall be deemed to be
authorized effective the day after the time allowed for protest. If a
protest is filed and not withdrawn within 30 days after the time
allowed for filing a protest, the instant request for authorization
will be considered by the Commission.
---------------------------------------------------------------------------

    \2\ 18 CFR 157.205.
    \3\ Persons include individuals, organizations, businesses,
municipalities, and other entities. 18 CFR 385.102(d).
---------------------------------------------------------------------------

    Protests must comply with the requirements specified in section
157.205(e) of the Commission's regulations,\4\ and must be submitted by
the protest deadline, which is February 14, 2022. A protest may also
serve as a motion to intervene so long as the protestor states it also
seeks to be an intervenor.
---------------------------------------------------------------------------

    \4\ 18 CFR 157.205(e).
---------------------------------------------------------------------------

Interventions

    Any person has the option to file a motion to intervene in this
proceeding. Only intervenors have the right to request rehearing of
Commission orders issued in this proceeding and to subsequently
challenge the Commission's orders in the U.S. Circuit Courts of Appeal.
    To intervene, you must submit a motion to intervene to the
Commission in accordance with Rule 214 of the Commission's Rules of
Practice and Procedure \5\ and the regulations under the NGA \6\ by the
intervention deadline for the project, which is February 14, 2022. As
described further in Rule 214, your motion to intervene must state, to
the extent known, your position regarding the proceeding, as well as
your interest in the proceeding. For an individual, this could include
your status as a landowner, ratepayer, resident of an impacted
community, or recreationist. You do not need to have property directly
impacted by the project in order to intervene. For more information
about motions to intervene, refer to the FERC website at https://www.ferc.gov/resources/guides/how-to/intervene.asp.
---------------------------------------------------------------------------

    \5\ 18 CFR 385.214.
    \6\ 18 CFR 157.10.
---------------------------------------------------------------------------

    All timely, unopposed motions to intervene are automatically
granted by operation of Rule 214(c)(1). Motions to intervene that are
filed after the intervention deadline are untimely and may be denied.
Any late-filed motion to intervene must show good cause for being late
and must explain why the time limitation should be waived and provide
justification by reference to factors set forth in Rule 214(d) of the
Commission's Rules and Regulations. A person obtaining party status
will be placed on the service list maintained by the Secretary of the
Commission and will receive copies (paper or electronic) of all
documents filed by the applicant and by all other parties.

Comments

    Any person wishing to comment on the project may do so. The
Commission considers all comments received about the project in
determining the appropriate action to be taken. To ensure that your
comments are timely and properly recorded, please submit your comments
on or before February 14, 2022. The filing of a comment alone will not
serve to make the filer a party to the proceeding. To become a party,
you must intervene in the proceeding.

How To File Protests, Interventions, and Comments

    There are two ways to submit protests, motions to intervene, and
comments. In both instances, please reference the Project docket number
CP22-27-000 in your submission.
    (1) You may file your protest, motion to intervene, and comments by
using the Commission's eFiling feature, which is located on the
Commission's website (www.ferc.gov) under the link to Documents and
Filings. New eFiling users must first create an account by clicking on
``eRegister.'' You will be asked to select the type of filing you are
making; first select General'' and then select ``Protest'',
``Intervention'', or ``Comment on a Filing''; or \7\
---------------------------------------------------------------------------

    \7\ Additionally, you may file your comments electronically by
using the eComment feature, which is located on the Commission's
website at www.ferc.gov under the link to Documents and Filings.
Using eComment is an easy method for interested persons to submit
brief, text-only comments on a project.
---------------------------------------------------------------------------

    (2) You can file a paper copy of your submission by mailing it to
the address below. Your submission must reference the Project docket
number CP22-27-000.
    To mail via USPS, use the following address: Kimberly D. Bose,
Secretary, Federal Energy Regulatory Commission, 888 First Street NE,
Washington, DC 20426.
    To mail via any other courier, use the following address: Kimberly
D. Bose, Secretary, Federal Energy Regulatory Commission, 12225 Wilkins
Avenue, Rockville, Maryland 20852.
    The Commission encourages electronic filing of submissions (option
1 above) and has eFiling staff available to assist you at (202) 502-
8258 or [email protected]
    Protests and motions to intervene must be served on the applicant
either by mail or email (with a link to the document) at: David A.
Alonzo, Manager, Project Authorizations, Gas Transmission Northwest
LLC, 700 Louisiana Street, Suite 1300, Houston, Texas, 77002-2700, at
(832) 320-5477; or email at [email protected]. Any subsequent
submissions by an intervenor must be served on the applicant and all
other parties to the proceeding. Contact information for parties can be
downloaded from the service list at the eService link on FERC Online.

Tracking the Proceeding

    Throughout the proceeding, additional information about the project
will be available from the Commission's Office of External Affairs, at
(866) 208-FERC, or on the FERC website at www.ferc.gov using the
``eLibrary'' link as described above. The eLibrary link also provides
access to the texts of all formal documents issued by the Commission,
such as orders, notices, and rulemakings.
    In addition, the Commission offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. For more information and to register, go to
www.ferc.gov/docs-filing/esubscription.asp.

    Dated: December 15, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021-27787 Filed 12-22-21; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 78, Number 45 (Thursday, March 7, 2013)]
[Notices]
[Page 14784]
[FR Doc No: 2013-05258]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL13-48-000]

Delaware Division of the Public Advocate, Delaware Municipal
Electric Corporation, Inc., Delaware Public Service Commission,
Maryland Office of People's Counsel, Maryland Public Service
Commission, New Jersey Board of Public Utilities, New Jersey Division
of Rate Counsel, Office of the People's Counsel of the District of
Columbia, Public Service Commission of the District of Columbia v.
Baltimore Gas and Electric Company, Pepco Holdings, Inc., Potomac
Electric Power Company, Delmarva Power & Light Company, Atlantic City
Electric Company;

Notice of Complaint

    Take notice that on February 27, 2013, pursuant to Rules 206 of the
Rules of Practice and Procedure of the Federal Energy Regulatory
Commission (Commission), 18 CFR 385.206 (2013) and section 206 of the
Federal Power Act, 16 U.S.C. 824(e), Delaware Division of the Public
Advocate, Delaware Municipal Electric Corporation, Inc., Delaware
Public Service Commission, Maryland Office of People's Counsel,
Maryland Public Service Commission, New Jersey Board of Public
Utilities, New Jersey Division of Rate Counsel, Office of the People's
Counsel of the District of Columbia, and Public Service Commission of
the District of Columbia (collectively, Complainants) filed a formal
complaint against Baltimore Gas and Electric Company (BGE), Pepco
Holdings, Inc. (PHI), and affiliates; Potomac Electric Power Company,
Delmarva Power & Light Company, and Atlantic City Electric Company
(Respondents), seeking a Commission order to reduce the base return
equity used in BGE's and PHI Companies' formula transmission rates to
8.7 percent and directing the Respondents to submit compliance filings
to implement the changes to the formula transmission rate
implementation protocols, as more fully described in the complaint.
    The Complainants certify that copies of the complaint were served
on the contacts for the Respondents as listed on the Commission's list
of Corporate Officials and on parties the Complainants reasonably
expect to be affected by this Complaint.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. The Respondent's
answer and all interventions, or protests must be filed on or before
the comment date. The Respondent's answer, motions to intervene, and
protests must be served on the Complainants.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the web site that enables subscribers to receive email
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5:00 p.m. Eastern Time on March 19, 2013.

    Dated: February 28, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013-05258 Filed 3-6-13; 8:45 am]
BILLING CODE 6717-01-P


                         Plant Incorporated Protectant
                                End Use Product

                              C5 HoneySweet Plum

Active Ingredients:

Plum Pox Virus Resistance Gene (Plum Pox Viral Coat Protein Gene) ......0.0002% (w/w)

Other Ingredients:
..........................................................................................99.9998% (w/w)

Total:................................................................................100%

  EPA Registration Number 11312-I

USDA-ARS Appalachian Fruit Research Station
2217 Wiltshire Road
Kearnysville, WV 25430

                              Directions for Use

It is a violation of Federal law to use this product in any manner inconsistent with its labeling. Not for use in organic agriculture.

This label applies to all plant propagation materials incorporating the plum pox virus resistance gene, including but not limited to, plantlets, cuttings and trees. The recipient of plant propagation materials agrees to comply with this label. All replicates, derivatives and progeny of these materials must be clearly identified. The Plum Pox Viral Coat Protein Gene was utilized in developing this Plum Pox Virus Resistant Plum; henceforth, it will be designated by the acronym PPVR. Identification is required. This is accomplished by securely attaching the following information to all plant propagation materials:  "PPVR not for use in organic agriculture."

                              Warranty Statement

C5 HoneySweet Plum has been transformed to express the plum pox virus resistance gene for the control of plum pox virus.  To the extent permitted by State Law, user assumes all risks of use and handling of this material not in strict accordance with directions given here with.